Prostate Cancer - Results from #24620

Multitargeted tyrosine kinase inhibition produces discordant changes between 99mTc-MDP bone scans and other disease biomarkers: Analysis of a phase II study of sunitinib for metastatic castration-resistant prostate cancer - Abstract October 9, 2012

The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiation - Abstract October 9, 2012

A comparison of preplan MRI and preplan CT-based prostate volume with intraoperative ultrasound-based prostate volume in real-time permanent brachytherapy - Abstract October 9, 2012

Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programme - Abstract October 9, 2012

Anogenital distance and the risk of prostate cancer - Abstract October 9, 2012

Prevalence and predictors of selenium and vitamin E supplementation in a urology population - Abstract October 9, 2012

Uncertainty and perception of danger among patients undergoing treatment for prostate cancer - Abstract October 9, 2012

Management of older men with clinically localized prostate cancer: The significance of advanced age and comorbidity - Abstract October 9, 2012

Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC) - Abstract October 9, 2012

Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: A multi-arm multi-stage randomized controlled trial - Abstract October 8, 2012

Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: A matched-pair analysis based on risk-groups - Abstract October 8, 2012

Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial - Abstract October 8, 2012

Neoadjuvant hormonal therapy use and the risk of death in men with prostate cancer treated with brachytherapy who have no or at least a single risk factor for coronary artery disease - Abstra October 8, 2012

Costs of radical prostatectomy for prostate cancer: A systematic review - Abstract October 8, 2012

Short-term androgen-deprivation therapy improves prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy - Abstract October 8, 2012

Impact of delay after biopsy and post-biopsy haemorrhage on prostate cancer tumour detection using multi-parametric MRI: A multi-reader study - Abstract October 8, 2012

Pre-biopsy magnetic resonance imaging and prostate cancer detection: Comparison of random and MRI-targeted biopsies using three different techniques of MRI-TRUS image registration - Abstract October 8, 2012

Placement of retrievable self-expandable metallic stents with barbs into patients with obstructive prostate cancer - Abstract October 8, 2012

Prostate cancer: Germline prediction for a commonly variable malignancy - Abstract October 5, 2012

Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: Data from ethnic Chinese patients with localized prostate cancer - Abstract October 5, 2012

Page 1232 of 1434